Skip to main content
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. — Investor Relations & Filings

Ticker · PPCB ISIN · US74346N4043 LEI · 549300Q3HY827FNV8Y56 US Professional, scientific and technical activities
Open in API
Filings indexed 412 across all filing types
Latest filing 2015-12-10 Capital/Financing Update
Country US United States of America
Listing US PPCB

About Propanc Biopharma, Inc.

https://www.propanc.com/

Propanc Biopharma, Inc. is a clinical-stage company developing cancer treatments focused on preventing tumor recurrence and metastasis. Its lead candidate, PRP, is a pancreatic proenzyme formulation designed to target and eradicate cancer stem cells. The therapeutic approach aims to suppress tumor progression by controlling cancer cell migration, inhibiting the formation of tumor blood vessels, and inducing cell death. The company's primary focus is on developing long-term therapies for patients with solid tumors, such as pancreatic cancer.

Recent filings

Filing Released Lang Actions
FORM S-1/A
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to a Form S-1 Registration Statement filed with the SEC. It includes detailed information about securities issuance, convertible notes, promissory notes, and financing agreements. The Form S-1 is a registration statement used for initial public offerings or other securities offerings, focusing on capital raising activities. The content is primarily about financing and capital structure updates, including terms of convertible notes and promissory notes, and securities purchase agreements. There is no indication that this is an annual report, earnings release, or other financial performance report. The document is not a proxy statement, board management change, or legal proceeding report. Given the focus on securities issuance and financing terms, the appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a mere announcement but a substantive filing about financing.
2015-12-10 English
Regulatory Filings 2015
Regulatory Filings
2015-12-07 English
Regulatory Filings 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of the effective date for a Registration Statement on Form S-1. It is a formal correspondence related to a securities registration process, not a financial report or detailed filing. The document is short (1740 characters) and does not contain financial data or report content. It is a regulatory communication related to the registration process, thus best classified as a Regulatory Filing (RNS).
2015-12-04 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC). It is a registration statement under the Securities Act of 1933, used by companies planning to go public or register securities for sale. The text includes details about the securities being registered, offering price, selling shareholders, and a preliminary prospectus describing the company's business, risk factors, and financial condition. This is not an annual report, earnings release, or any other financial report but a registration statement for securities offering. According to the filing definitions, this corresponds to a Capital/Financing Update (CAP) as it relates to company fundraising and securities registration.
2015-11-23 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, which is used to announce unscheduled material events or corporate changes. The content includes a press release about preclinical study results and a patent filing, but does not contain financial statements or detailed financial analysis. It is not an earnings release, annual report, or interim report. The document is a regulatory announcement of a corporate event, fitting the category of Regulatory Filings (RNS). The document length is 5557 characters, which is consistent with a typical 8-K filing. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2015-11-17 English
10-Q
Interim / Quarterly Report Q1 2016
2015-11-16 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.